A5064891807- Medication Adherence and Compliance
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical Economics and Policy
- Lipoproteins and Cardiovascular Health
- Acute Myocardial Infarction Research
- Cardiac Imaging and Diagnostics
- Cerebrovascular and Carotid Artery Diseases
- Natural product bioactivities and synthesis
- Heart Failure Treatment and Management
- Cardiac Structural Anomalies and Repair
- Coronary Interventions and Diagnostics
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrest and Resuscitation
- Mechanical Circulatory Support Devices
- Phytochemistry and Biological Activities
- Alkaloids: synthesis and pharmacology
- Antiplatelet Therapy and Cardiovascular Diseases
- Chronic Lymphocytic Leukemia Research
- Acute Ischemic Stroke Management
University of Turin
2022-2025
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino
2022-2025
Deleted Institution
2023
National Institute of Neurological Disorders and Stroke
2023
The clinical outcomes of patients with left ventricular assist devices (LVAD) have steadily improved, unveiling late right failure (RVF) and aortic regurgitation (AR) as drivers long-term mortality. continuous-flow LVAD physiology the patient's pre-existing features predispose to these complications, recently labeled hemodynamic-related events (HDREs). We present case an carrier complicated by both RVF AR, in which a comprehensive hemodynamic echo-guided ramp test was carried out. A...
Background: The impact of statin therapy on cardiovascular outcomes after ST-elevation acute myocardial infarction (STEMI) in real-world patients is understudied. Objectives: to identify predictors low adherence and discontinuation within 6 months STEMI estimate their at one year follow-up. Methods: We evaluated by comparing the number bought tablets expected ones 1 follow-up through pharmacy registries. A total 6043 admitted from 2012 2017 were enrolled FAST registry followed up for 4,7±1,6...
Beta-blockers are a crucial part of post-myocardial infarction (MI) pharmacological therapy. Recent studies have raised questions about their efficacy in patients without reduced left ventricular ejection fraction (LVEF). This study aims to assess adherence beta-blockers after discharge for ST-segment elevation myocardial (STEMI) and the impact on outcomes based LVEF at discharge. The retrospective registry FAST-STEMI evaluated real-world main cardiovascular drugs STEMI between 2012 2017 by...
An abstract is not available for this content so a preview has been provided. As you have access to content, full PDF via the ‘Save PDF’ action button.
Abstract Background The impact of drug therapy on cardiovascular outcomes after ST-elevation acute myocardial infarction (STEMI) in patients with preserved ejection fraction (EF) remains unknown. Purpose To identify the adherence to statins, ACEi/ARB and beta-blockers all-cause mortality at one year index event total follow-up length affected by STEMI EF. Methods We evaluated real-world most common drugs comparing number tablets purchased inour region drugstores analyzing their registries,...
Abstract Background The impact of beta-blocker therapy on cardiovascular outcomes after ST-elevation acute myocardial infarction (STEMI) is debated. Adherence to beta-blockers and effect long term are also fields with significant knowledge gaps. Purpose To identify predictors lower compliance estimate its mortality during the first year follow-up index event. Methods We evaluated real-world adherence most common drugs by comparing number tablets bought in pharmacies expected needed at 1...
Abstract Background The impact of statin therapy on cardiovascular outcomes after ST-elevation acute myocardial infarction (STEMI) in real-world patients is understudied. Purpose aim this study was to identify predictors low compliance and estimate its (CV) mortality the first year index event. Methods We evaluated adherence most common drugs by comparing number bought tablets drugstores expected at 1 total follow-up length. A amount 6043 from 2012 2017 enrolled FAST STEMI registry followed...
Introduction: Among different coronary stents implanted in High Bleeding Risk (HBR) patients with an indication for short antiplatelet therapy, no comparisons terms of efficacy have been provided. Methods: A Network Meta Analysis was performed including all Randomized Controlled Trials comparing evaluated HBR patients. Major Adverse Cardiovascular Events (MACEs) as defined by each included trial were the primary end point, whereas TLR (target lesion revascularization), TVR vessel stent...
ABSTRACT: Background and Aims: Atrial fibrillation (AF) is the most important cause of embolic stroke undetermined source (ESUS). Implantable loop recorder (ILR) demonstrated highest sensitivity for detecting it. This register was created to confirm high prevalence AF in patients after ESUS verify possible benefits on clinical outcomes such as TIA (Transient Ischaemic Attack)/stroke recurrence death using ILR. Methods: A total 278 admitted “Molinette” Hospital Stroke Unit department between...
Abstract Background and Aims AF (Atrial Fibrillation) is the most important cause of Embolic Stroke Undetermined Source (ESUS). Implantable Loop Recorder (ILR) demonstrated highest sensitivity for detecting post-stroke asymptomatic AF. This register was created to assess prevalence episodes in patients after ESUS verify possible benefits on clinical outcomes such as TIA or stroke recurrence death using ILR. Methods 278 admitted Unit “Città della Salute e Scienza” hospital Torino between 2011...